(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566866

頭蓋内圧（ICP）モニタリング市場：技術別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Intracranial Pressure Monitoring Market By Technique, By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 216 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
頭蓋内圧（ICP）モニタリング市場：技術別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 216 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

頭蓋内圧（ICP）モニタリング市場

頭蓋内圧（ICP）モニタリング市場は、2023年に4億米ドルと評価され、2024年から2033年にかけてCAGR 5.1%で成長し、2033年には6億米ドルに達すると予測されています。

ICPモニタリングは、頭蓋腔内の脳脊髄液や血液などの特定の流体が及ぼす頭蓋内の圧力を測定する診断検査です。カテーテルやセンサーを脳の脳脊髄液腔に挿入して圧力を測定します。ICPモニタリングの実施は、脳卒中、外傷性脳損傷、脳腫瘍、神経疾患など、さまざまな病状において極めて重要です。ヘルスケアプロバイダーはICPモニタリングを通じて脳損傷の強度を評価し、頭蓋内動態の変化を特定し、治療を決定します。

継続的な技術進歩によるICPモニタリングの有効性の急増が市場の主な促進要因です。ワイヤレス接続、センサーの小型化、デジタルヘルスプラットフォームとの同化により、ヘルスケアプロバイダーはリアルタイムのデータを収集し、十分な情報に基づいた意思決定を行い、神経クリティカルな環境における患者ケアを向上させることができるようになった。将来的には、非侵襲的ICPモニタリングの動向がヘルスケア現場で主流になると予測されます。現在、経頭蓋ドップラー超音波法、脳組織共鳴法、静脈眼圧計など、既存の非侵襲的手技の限界を緩和するための研究開発努力が急ピッチで進められています。

しかし、最先端技術の進歩は、診断検査の高額化を招き、多くの個人にとって手の届かないものとなっています。さらに、ICPモニタリングに関連する機器を調達するための初期費用が高く、較正、メンテナンス、消耗品費もかかるため、中小規模の医療施設では投資することが難しいです。それとは逆に、AIの導入は頭蓋内圧（ICP）モニタリング市場に新たな道を開くと期待されるイノベーションの分野です。AIは、機器から生成される大規模なデータセットを分析し、人間の観察ではスキップ可能な異常を特定すると予想されます。AIの予測モデルによって提供される提案は、医療対応のオンタイムデリバリーを支援し、したがって患者の転帰を改善すると予測されます。

セグメントレビュー

頭蓋内圧（ICP）モニタリング市場は、技術、用途、エンドユーザー、地域に区分されます。手技別では、侵襲性と非侵襲性に二分されます。アプリケーション別では、外傷性脳損傷、脳内出血、髄膜炎、その他に分けられます。エンドユーザー別では、病院、診療所、民間医療機関、外傷センター、政府・研究機関に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

手技別では、非侵襲性が2023年の市場で最も高い収益を上げました。

用途別では、外傷性脳損傷セグメントが2023年に最も高い収益を上げました。

エンドユーザー別では、病院セグメントが2023年に市場でより高いステークを獲得しました。

本レポートのカスタマイズの可能性（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 頭蓋内圧（ICP）モニタリング市場：技術別

  • 市場概要
  • 侵襲性
  • 非侵襲性

第5章 頭蓋内圧（ICP）モニタリング市場：用途別

  • 市場概要
  • 外傷性脳損傷
  • 脳内出血
  • 髄膜炎
  • その他

第6章 頭蓋内圧（ICP）モニタリング市場：エンドユーザー別

  • 市場概要
  • 病院
  • 診療所
  • 個人医院
  • 外傷センター
  • 政府機関および研究機関

第7章 頭蓋内圧（ICP）モニタリング市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の頭蓋内圧（ICP）モニタリング市場
    • カナダの頭蓋内圧（ICP）モニタリング市場
    • メキシコの頭蓋内圧（ICP）モニタリング市場
  • 欧州
    • 主な市場動向と機会
    • フランスの頭蓋内圧（ICP）モニタリング市場
    • ドイツの頭蓋内圧（ICP）モニタリング市場
    • イタリアの頭蓋内圧（ICP）モニタリング市場
    • スペインの頭蓋内圧（ICP）モニタリング市場
    • 英国の頭蓋内圧（ICP）モニタリング市場
    • その他欧州の頭蓋内圧（ICP）モニタリング市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の頭蓋内圧（ICP）モニタリング市場
    • 日本の頭蓋内圧（ICP）モニタリング市場
    • インド頭蓋内圧（ICP）モニタリング市場
    • 韓国の頭蓋内圧（ICP）モニタリング市場
    • オーストラリア頭蓋内圧（ICP）モニタリング市場
    • その他アジア太平洋の頭蓋内圧（ICP）モニタリング市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの頭蓋内圧（ICP）モニタリング市場
    • 南アフリカの頭蓋内圧（ICP）モニタリング市場
    • サウジアラビアの頭蓋内圧（ICP）モニタリング市場
    • その他のラテンアメリカ・中東・アフリカの頭蓋内圧（ICP）モニタリング市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • BrainLAB
  • Natus Medical Incorporated
  • Integra LifeSciences
  • GE Healthcare
  • Teleflex Incorporated
  • Sick AG
  • Smiths Medical
  • Koninklijke Philips N.V
  • Elekta AB
  • AMETEK
目次
Product Code: A149770

Intracranial Pressure (ICP) Monitoring Market

The intracranial pressure (ICP) monitoring market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

ICP monitoring is a diagnostic test for measuring the pressure inside the skull, exerted by certain fluids such as cerebrospinal fluid and blood within the cranial cavity. A catheter or sensor is inserted into the cerebrospinal fluid space of brain in this procedure to gauge the pressure. Conducting ICP monitoring is pivotal in various medical conditions, including stroke, traumatic brain injury, brain tumors, and neurological disorders. Healthcare providers assess the intensity of brain injury through ICP monitoring, identify modifications in intracranial dynamics, and make treatment decisions.

Surge in the efficacy of ICP monitoring due to continuous technological advancements is a major driver of the market. Wireless connectivity, miniaturization of sensors, and assimilation with digital health platforms have enabled healthcare providers to garner real-time data, make well-informed decisions, and elevate patient care in neurocritical settings. In future, the trend of non-invasive ICP monitoring is projected to dominate in the healthcare settings. Currently, R&D efforts are in full pace to mitigate the limitations of existing non-invasive procedures such as transcranial doppler ultrasonography, brain tissue resonance, and venous ophthalmodynamometry.

However, cutting-edge technological advancements result in high cost of diagnostic tests, making it unaffordable for several individuals. Moreover, the high initial cost of procuring equipment associated with ICP monitoring; along with calibration, maintenance, and consumable expenses; makes it challenging for several small & medium-sized healthcare facilities to invest in them. On the contrary, the deployment of AI is a field of innovation expected to open new avenues for the intracranial pressure (ICP) monitoring market. AI is anticipated to analyze large datasets generated from the equipment and identify the abnormalities that are possible skippable by human observation. Suggestions offered by predictive model of AI are projected to aid in on-time delivery of medical responses, hence improving patient outcomes.

Segment Review

The intracranial pressure (ICP) monitoring market is segmented into technique, application, end user, and region. On the basis of technique, the market is bifurcated into invasive and non-invasive. By application, it is divided into traumatic brain injury, intracerebral hemorrhage, meningitis, and others. Depending on end user, it is classified into hospital, clinics, private medical offices, trauma centers, and government & research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technique, the non-invasive segment generated the highest revenue in the market in 2023.

By application, the traumatic brain injury segment was the highest revenue generator in 2023

Depending on end user, the hospital segment acquired higher stakes of the market in 2023.

Competition Analysis

The major players operating in the global intracranial pressure (ICP) monitoring market include BrainLAB, Natus Medical Incorporated, Integra LifeSciences, GE Healthcare, Teleflex Incorporated, Sick AG, Smiths Medical, Koninklijke Philips N.V, Elekta AB, and AMETEK. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technique

  • Invasive
  • Non-Invasive

By Application

  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Meningitis
  • Others

By End User

  • Hospital
  • Clinics
  • Private Medical Offices
  • Trauma Centers
  • Government and Research Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • BrainLAB
    • Natus Medical Incorporated
    • Integra LifeSciences
    • GE Healthcare
    • Teleflex Incorporated
    • Sick AG
    • Smiths Medical
    • Koninklijke Philips N.V
    • Elekta AB
    • AMETEK

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Technique
  • 4.2. Invasive
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Non-Invasive
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Traumatic Brain Injury
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Intracerebral Hemorrhage
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Meningitis
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospital
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Private Medical offices
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Trauma Centers
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Government And Research Organizations
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Technique
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intracranial Pressure (ICP) Monitoring Market
      • 7.2.6.1. Market Size and Forecast, By Technique
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intracranial Pressure (ICP) Monitoring Market
      • 7.2.7.1. Market Size and Forecast, By Technique
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intracranial Pressure (ICP) Monitoring Market
      • 7.2.8.1. Market Size and Forecast, By Technique
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Technique
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intracranial Pressure (ICP) Monitoring Market
      • 7.3.6.1. Market Size and Forecast, By Technique
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intracranial Pressure (ICP) Monitoring Market
      • 7.3.7.1. Market Size and Forecast, By Technique
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intracranial Pressure (ICP) Monitoring Market
      • 7.3.8.1. Market Size and Forecast, By Technique
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intracranial Pressure (ICP) Monitoring Market
      • 7.3.9.1. Market Size and Forecast, By Technique
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intracranial Pressure (ICP) Monitoring Market
      • 7.3.10.1. Market Size and Forecast, By Technique
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intracranial Pressure (ICP) Monitoring Market
      • 7.3.11.1. Market Size and Forecast, By Technique
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Technique
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intracranial Pressure (ICP) Monitoring Market
      • 7.4.6.1. Market Size and Forecast, By Technique
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intracranial Pressure (ICP) Monitoring Market
      • 7.4.7.1. Market Size and Forecast, By Technique
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intracranial Pressure (ICP) Monitoring Market
      • 7.4.8.1. Market Size and Forecast, By Technique
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intracranial Pressure (ICP) Monitoring Market
      • 7.4.9.1. Market Size and Forecast, By Technique
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intracranial Pressure (ICP) Monitoring Market
      • 7.4.10.1. Market Size and Forecast, By Technique
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intracranial Pressure (ICP) Monitoring Market
      • 7.4.11.1. Market Size and Forecast, By Technique
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Technique
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intracranial Pressure (ICP) Monitoring Market
      • 7.5.6.1. Market Size and Forecast, By Technique
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intracranial Pressure (ICP) Monitoring Market
      • 7.5.7.1. Market Size and Forecast, By Technique
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intracranial Pressure (ICP) Monitoring Market
      • 7.5.8.1. Market Size and Forecast, By Technique
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intracranial Pressure (ICP) Monitoring Market
      • 7.5.9.1. Market Size and Forecast, By Technique
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. BrainLAB
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Natus Medical Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Integra LifeSciences
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. GE Healthcare
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Teleflex Incorporated
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Sick AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Smiths Medical
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Koninklijke Philips N.V
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Elekta AB
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AMETEK
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments